Satoshi Kamido
Papers
1
Total Citations
4
H-Index
1
About
Satoshi Kamido is a clinician-researcher whose work sits at the critical intersection of oncology and bone health, with a particular focus on the skeletal consequences of prostate cancer treatment. His primary research area involves the use of advanced quantitative imaging—specifically quantitative computed tomography (QCT)—to precisely measure bone mineral density changes in patients undergoing androgen deprivation therapy (ADT). Kamido’s most notable contribution is a 2024 propensity-matched cohort study that rigorously quantified the detrimental impact of ADT on lumbar spine bone health, demonstrating that ADT accelerates bone loss beyond what is seen in matched controls. This work, which has already garnered 4 citations in a short time, provides clinicians with actionable data to better assess and mitigate fragility fracture risk in prostate cancer survivors. By moving beyond standard DXA scans to more sensitive QCT measurements, Kamido has helped refine risk stratification for this growing patient population. His research is particularly valuable for oncologists, urologists, and endocrinologists seeking evidence-based strategies to preserve skeletal integrity during hormone therapy.
Research Focus
Key Achievements
Top Papers
- 1